POST Online Media Lite Edition


CMP Therapeutics appoints Neill Moray Mackenzie as CEO

Staff writer |
London, United Kingdom - July 29, 2010, London, United Kingdom - CMP Therapeutics, a biopharmaceutical company, announces the appointment of Neill Moray Mackenzie to the role of chief executive officer.

Dr. Mackenzie brings to CMPT a long record of executive board level management within the biotechnology and pharmaceutical industries at companies including Cambridge Genetics Ltd, Oxford Biomedica plc (an LSE listed company), Avidex Ltd (now Immunocore) and most recently as the SVP for Business Development and Corporate Strategy at Medigene AG (a Borse-listed company) and CEO of Roji Ltd (London).

 LATEST MOVES FROM United Kingdom 

John Lewis Of Hungerford appoints Kiran Noonan as acting chair
Ferroglobe appoints Marco Levi as chief executive officer
Tullow Oil appoints Dorothy Thompson as interim chair
Arla Foods says CFO Natalie Knigh to leave
Superdry promotes Julian Dunkerton to full time CEO

What to read next

Topaz appoints Emmet O'Neill as new chief executive
Ryanair appoints head of sales & marketing
BHP Billiton appoints Ken MacKenzie as chairman